114 related articles for article (PubMed ID: 875870)
1. [Diagnosis of skeletal metastases in prostatic cancer using gamma camera (author's transl)].
Langhammer H; Sintermann R; Kempken K; Hör G; Pabst HW; Fendl M
Med Klin; 1977 May; 72(21):942-51. PubMed ID: 875870
[TBL] [Abstract][Full Text] [Related]
2. [The diagnostic value of radiological, nuclear medicine and biochemical methods for detection of bone metastases in carcinoma of the prostate (author's transl)].
Rost A; Fiedler U; Marshall F; Koppenhagen K
Radiologe; 1977 Jun; 17(6):249-55. PubMed ID: 887744
[TBL] [Abstract][Full Text] [Related]
3. [Solitary metastasis of prostate cancer in the tibia].
Barkow U; Weissbach L; Strohmeier A; Schöder H; Friedrich M
Aktuelle Radiol; 1994 Sep; 4(5):274-6. PubMed ID: 7527252
[TBL] [Abstract][Full Text] [Related]
4. [Scintigraphic presentation of bone metastases in prostatic carcinoma].
Dienstl VE; Hinteregger H; Bergmann M; Herbinger W
Wien Med Wochenschr; 1975 Jun; 125(25-27):388-91. PubMed ID: 1220285
[No Abstract] [Full Text] [Related]
5. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
6. Radioisotopic detection of osseius metastases. Evaluation of 99mTc polyphosphate and 99mTc pyrophosphate.
Fletcher JW; Solaric-George E; Henry RE; Donati RM
Arch Intern Med; 1975 Apr; 135(4):553-7. PubMed ID: 166626
[TBL] [Abstract][Full Text] [Related]
7. Whole body skeletal scintiphotography in the detection of occult metastatic breast carcinomas.
Hopkins GB; Kristensen KA
Calif Med; 1973 Oct; 119(4):10-3. PubMed ID: 4201387
[TBL] [Abstract][Full Text] [Related]
8. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
9. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
[TBL] [Abstract][Full Text] [Related]
10. Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Flusser G; Zuriel L; Kollender Y; Lerman H; Lievshitz G; Ron I; Mishani E
J Nucl Med; 2004 Feb; 45(2):272-8. PubMed ID: 14960647
[TBL] [Abstract][Full Text] [Related]
11. The reliability of 99mmTc-pyrophosphate scintigraphy in the diagnosis of bony metastases.
Nordman E; Marjamäki H; Tannila O
Ann Clin Res; 1977 Feb; 9(1):31-4. PubMed ID: 883754
[TBL] [Abstract][Full Text] [Related]
12. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
13. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
14. Correlation of neoplasms with incidence and localization of skeletal metastases: An analysis of 1,355 diphosphonate bone scans.
Tofe AJ; Francis MD; Harvey WJ
J Nucl Med; 1975 Nov; 16(11):986-9. PubMed ID: 810549
[TBL] [Abstract][Full Text] [Related]
15. [Comparative investigations of osteotropic radiopharmaceuticals. V. Demonstration of abnormal uptake with various scanners (author's transl)].
Creutzig H; Bornemann H
Rofo; 1977 Sep; 127(3):243-7. PubMed ID: 143428
[TBL] [Abstract][Full Text] [Related]
16. Bone scan patterns of patients with diffuse metastatic carcinoma of the axial skeleton.
Witherspoon LR; Blonde L; Shuler SE; McBurney DB
J Nucl Med; 1976 Apr; 17(4):253-7. PubMed ID: 176333
[TBL] [Abstract][Full Text] [Related]
17. Serial Fluorine-18 bone scans in the follow-up of carcinoma of the prostate.
Buck AC; Chisholm GD; Merrick MV; Lavender JP
Br J Urol; 1975 Jun; 47(3):287-94. PubMed ID: 1095103
[TBL] [Abstract][Full Text] [Related]
18. [An analysis of the radiological appearance of osteoplastic metastases and osteitis deformans (Paget's disease) (author's transl)].
Friedrich M; Gerstenberg E; Kochanek W; Rost A
Rofo; 1976 Nov; 125(5):404-13. PubMed ID: 137184
[TBL] [Abstract][Full Text] [Related]
19. [Early diagnosis of metastases in prostatic carcinoma].
Rutishauser G
Dtsch Med Wochenschr; 1972 Sep; 97(35):1304-5. PubMed ID: 5050244
[No Abstract] [Full Text] [Related]
20. Serial bone scintigraphy for assessing the effectiveness of treatment of osseous metastases from prostatic cancer.
Langhammer H; Sintermann R; Hör G; Pabst HW
Nuklearmedizin; 1978 Jul; 17(3):87-91. PubMed ID: 568257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
